Acorda Therapeutics, Inc.

Acorda Therapeutics, Inc. is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. The momentum for this stock is not very good. Acorda Therapeutics, Inc. is not a good growth stock. Acorda Therapeutics, Inc. is not very popular among insiders. Acorda Therapeutics, Inc. is a good stock to invest in, but there are better stocks to choose.
Log in to see more information.
Acorda Therapeutics, Inc. engages in the development of therapies that restore function and improve...

News

Acorda Therapeutics, Inc. (NASDAQ:ACOR) Short Interest Update
Acorda Therapeutics, Inc. (NASDAQ:ACOR) Short Interest Update

Zolmax Acorda Therapeutics, Inc. (NASDAQ:ACOR - Get Free Report) was the recipient of a large decline in short interest in March. As of March 31st, there was short interest totalling 8,100 shares, a...\n more…

Acorda Therapeutics (NASDAQ:ACOR) Now Covered by Analysts at StockNews.com
Acorda Therapeutics (NASDAQ:ACOR) Now Covered by Analysts at StockNews.com

Ticker Report Research analysts at StockNews.com started coverage on shares of Acorda Therapeutics (NASDAQ:ACOR - Get Free Report) in a research note issued on Friday. The brokerage set a "buy" rating on the...\n more…

Acorda Therapeutics (NASDAQ:ACOR) Coverage Initiated at StockNews.com
Acorda Therapeutics (NASDAQ:ACOR) Coverage Initiated at StockNews.com

Ticker Report StockNews.com began coverage on shares of Acorda Therapeutics (NASDAQ:ACOR - Free Report) in a research report released on Thursday morning. The firm issued a buy rating on the biopharmaceutical...\n more…

Acorda Therapeutics announces Nasdaq delisting notification
Acorda Therapeutics announces Nasdaq delisting notification

Seeking Alpha - Healthcare Acorda Therapeutics announces Nasdaq delisting notification...\n more…

Acorda Therapeutics Announces Nasdaq Delisting Notification
Acorda Therapeutics Announces Nasdaq Delisting Notification

Business Wire Acorda Therapeutics, Inc. (Nasdaq: ACOR) announced that Nasdaq Stock Market ('Nasdaq') today notified the Company that it will suspend trading in and delist the Company's common stock, effective with...\n more…

Why Acorda Therapeutics Stock Is Down Nearly 90%
Why Acorda Therapeutics Stock Is Down Nearly 90%

Benzinga Acorda Therapeutics shares are trading lower by 87% during Tuesday's session. The company on Monday provided a series of business updates.\n more…